DRIO
DarioHealth
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
DRIO Profile
Dariohealth Corp.
A leading developer of medical devices and solutions to monitor blood glucose using smart phones
Healthcare Equipment and Supplies
08/11/2011
03/04/2016
NASDAQ Stock Exchange
196
12-31
Common stock
322 W. 57th St., New York, New York 10011
--
DarioHealth Corp., founded on August 11, 2011, is a Delaware corporation. Originally a direct-to-consumer digital therapy company, the company first solved the problem of how to attract users and support behavioral change to improve clinical outcomes of diabetes. Beginning in 2020, the company has implemented a strategy to transform its business model, adopting a business-to-consumer approach, leveraging the advantages of the consumer solutions platform to provide business growth opportunities in traditional health business channels by selling products to health plans and employers.